You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Injections, Subcutaneous

Showing 1 - 25 of 9,155
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer Trial in Daejeon (GB-5001A, GB-5001D, Oral cohort)

Recruiting
  • Alzheimer Disease
  • Daejeon, Korea, Republic of
    Chungnam National University Hospital
Nov 17, 2023

Hyperlipidemia Trial in Guangzhou (SHR-1209, Placebo)

Completed
  • Hyperlipidemia
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital ,The Second Affiliated Hospital of
Nov 29, 2022

Augmentation, Reconstruction Trial in Copenhagen (Scaffold and adipose-derived stromal cell enriched fat grafts)

Active, not recruiting
  • Augmentation
  • Reconstruction
  • Scaffold and adipose-derived stromal cell enriched fat grafts
  • Copenhagen, Søborg, Denmark
  • +1 more
Nov 24, 2022

Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury

Not yet recruiting
  • Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury
  • IncobotulinumtoxinA
  • Placebo
  • (no location specified)
Oct 13, 2023

Pain, Ecchymosis Trial in Sisli (Thermo mechanical device, local coolant spray, ice battery)

Completed
  • Pain
  • Ecchymosis
  • Thermo mechanical device
  • +2 more
  • Şişli, Istanbul, Turkey
    Istanbul Unıversıty- Cerrahpaşa
May 10, 2022

Healthy Volunteers Trial in Tempe (Vedolizumab SC)

Completed
Has Results
  • Healthy Volunteers
  • Vedolizumab SC
  • Tempe, Arizona
    Celerion
Jul 1, 2022

Type 2 Diabetes Trial (Acetaminophen/SHR20004, Acetaminophen/Placebo)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • (no location specified)
Nov 17, 2023

Healthy Trial in Singapore (LY3209590 (Formulation 1), LY3209590 (Formulation 2))

Not yet recruiting
  • Healthy
  • LY3209590 (Formulation 1)
  • LY3209590 (Formulation 2)
  • Singapore, Singapore
    Lilly Centre for Clinical Pharmacology
Jun 14, 2023

Healthy Volunteers Trial in Graz (NNC0582-0001, Placebo)

Recruiting
  • Healthy Volunteers
  • Graz, Austria
    Novo Nordisk Investigational Site
Dec 5, 2022

Opioid-use Disorder Trial in Tustin (BICX104, Vivitrol)

Recruiting
  • Opioid-use Disorder
  • Tustin, California
    Orange County Research Center
Jul 18, 2022

Newly Diagnosed MGMT Unmethylated Glioblastoma Trial in Durham (D2C7-IT, 2141-V11)

Not yet recruiting
  • Newly Diagnosed MGMT Unmethylated Glioblastoma
  • Durham, North Carolina
    Duke University Medical Center
Feb 7, 2023

Pediatric Growth Hormone Deficiency (PGHD) Trial in Chengdu (PEG-rhGH with new preparation, PEG-rhGH with present preparation)

Not yet recruiting
  • Pediatric Growth Hormone Deficiency (PGHD)
  • PEG-rhGH with new preparation
  • PEG-rhGH with present preparation
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Nov 12, 2023

Systemic Sclerosis Trial in France (Adipose tissue harvest, Autologous ASC, Placebo)

Recruiting
  • Systemic Sclerosis
  • Adipose tissue harvest
  • +2 more
  • Grenoble, France
  • +6 more
Mar 15, 2022

Healthy Volunteers Trial in Harrow (NNC0581-0001, Placebo)

Recruiting
  • Healthy Volunteers
  • Harrow, Middlesex, United Kingdom
    Novo Nordisk Investigational Site
Dec 5, 2022

Healthy Volunteers Trial in Qingdao (SIM0278 Injection/Placebo)

Recruiting
  • Healthy Volunteers
  • SIM0278 Injection/Placebo
  • Qingdao, China, Shandong, China
    Affiliated Hospital of Qingdao University
Aug 31, 2023

A Long-term, Post-marketing Safety Study of Palynziq in PKU

Recruiting
  • Phenylketonuria (PKU)
  • Cottbus, Germany
  • +4 more
Apr 3, 2023

Osteoarthritis Trial in Melbourne (OLP-1002)

Recruiting
  • Osteoarthritis
  • Melbourne, Victoria, Australia
    Emeritus Research
Jan 28, 2022

Moderate to Severe Atopic Dermatitis Trial (SHR-1819 injection or )

Not yet recruiting
  • Moderate to Severe Atopic Dermatitis
  • SHR-1819 injection or placebo
  • (no location specified)
Jan 4, 2022

Atopic Healthy Subjects, Adult Subjects With Mild Allergic Diseases Trial in Korea, Republic of (YH35324, Placebo, Omalizumab)

Completed
  • Atopic Healthy Subjects
  • Adult Subjects With Mild Allergic Diseases
  • Suwon-si, Gyeonggi-do, Korea, Republic of
  • +3 more
Jan 26, 2023

Osteoarthritis, Knee Trial (Denosumab 60 MG/ML Injectable Solution [Prolia], Placebo)

Not yet recruiting
  • Osteoarthritis, Knee
  • Denosumab 60 MG/ML Injectable Solution [Prolia]
  • Placebo
  • (no location specified)
Sep 28, 2022

Diabetes, Type 2 Trial in Lincoln (GZR-18, Placebo)

Recruiting
  • Diabetes Mellitus, Type 2
  • Lincoln, Nebraska
    Celerion
Dec 21, 2022

Ankylosing Spondylitis Trial (BCD-085, Placebo)

Completed
  • Ankylosing Spondylitis
  • (no location specified)
Oct 25, 2021

Atopic Healthy Subjects, Adult Subjects With Mild Allergic Diseases Trial in Seongnam-si, Suwon-si, Seoul (YH35324, Placebo,

Recruiting
  • Atopic Healthy Subjects
  • Adult Subjects With Mild Allergic Diseases
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +3 more
Nov 11, 2022

Allergic Disease, Chronic Spontaneous Urticaria, Chronic Inducible Urticaria Trial in Seongnam-si, Suwon-si, Seoul (YH35324,

Recruiting
  • Allergic Disease
  • +3 more
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +4 more
Jul 24, 2023

Osteoporosis Trial in Changsha (SHR-1222, Placebo)

Active, not recruiting
  • Osteoporosis
  • Changsha, Hunan, China
    2nd Xiangya Hospital , Chinese Academy of Medical Sciences
Jan 5, 2022